Healthcare Industry News: HSMN NewsFeed
News Release - January 22, 2018
Johnson & Johnson Vision Expands Parameter Offering for 1-DAY ACUVUE(R) MOIST Brand Contact Lenses for ASTIGMATISMNearly half of vision-corrected patients has astigmatism in at least one eye,(1) and full correction can provide improved visual quality of life(2)
JACKSONVILLE, Fla., Jan. 22, 2018 -- (Healthcare Sales & Marketing Network) -- Johnson & Johnson Vision today announced the U.S. launch of expanded parameters for 1-DAY ACUVUE® MOIST Brand Contact Lenses for ASTIGMATISM, a daily disposable contact lens that offers patients BLINK-STABILIZED® Design for clear, stable vision and LACREON® Technology that provides a cushion of moisture for long-lasting comfort.
Nearly 1 out of every 2 vision corrected patients has astigmatism in at least one eye,1 and full correction can provide them with improved visual quality of life.2 With the addition of 48% more lens parameters for patients with astigmatism, the 1-DAY ACUVUE® MOIST Brand Contact Lens family now offers coverage for nearly 96% of spherical and astigmatic eyes3 and the ACUVUE® Family of 1-Day Contact Lenses for Astigmatism now offers the largest range of parameters among daily disposable contact lenses.
Astigmatism is an imperfection in the curvature of the cornea that can cause blurred or distorted vision. Symptoms of uncorrected astigmatism may include eye strain and headaches, especially after reading or other prolonged visual tasks. Squinting also is a common symptom. Mild to moderate astigmatism can be corrected through eyeglasses, contact lenses or surgery.
"With nearly half of patients requiring correction for astigmatism in at least one eye, having access to 2,260 parameters helps ensure that nearly every astigmatic contact lens patient has the opportunity to try a leading daily disposable lens with 1-DAY ACUVUE MOIST® for ASTIGMATISM," said Giovanna E. Olivares, OD, Global Astigmatism Platform Director, Johnson & Johnson Vision Care, Inc. "And for the doctor and staff, being able to fit patients who previously may not have considered contact lenses at all is one more way that practices can deliver exceptional patient care."
The proprietary BLINK-STABILIZED® Design found in 1-DAY ACUVUE® MOIST for ASTIGMATISM works naturally with the eyelids, helping to keep the lens in the correct position. LACREON® Technology embeds a moisture-rich wetting agent into the lens creating a cushion of moisture that won't blink away over time. The result is reduced friction of the lens and greater end-of-day comfort.
1-DAY ACUVUE® MOIST for ASTIGMATISM provides Class II UV protection, blocking approximately 82% of UVA and 97% of UVB rays.+*
Johnson & Johnson Vision will launch expanded parameters of 1-DAY ACUVUE® MOIST for ASTIGMATISM through its operating company, Johnson & Johnson Vision Care, Inc.
For more than 30 years, Johnson & Johnson Vision has focused on improving vision through quality contact lenses, never compromising on its goal to create technologies that make meaningful differences in people's lives.
A deep understanding of patient lifestyle needs as well as those of eye care professionals has driven R&D to create innovative solutions designed to complement the natural function of the eye. By developing contact lenses based on a deep understanding of how the eye works, the ACUVUE® Brand strives to maximize the eye's natural wellbeing during contact lens wear, and give patients and eye care professionals an exceptional experience.
Johnson & Johnson Vision
Johnson & Johnson Vision, through its operating companies, is committed to improving and restoring sight for patients worldwide. Since debuting the world's first disposable soft contact lens in 1987, Johnson & Johnson Vision Care, Inc. has been helping patients see better through their world-leading ACUVUE® Brand Contact Lenses portfolio. In 2017, with the addition of Abbott Medical Optics Inc., the Johnson & Johnson Surgical Vision business, Johnson & Johnson invested further in eye health by expanding into cataract surgery, laser refractive surgery (LASIK) and consumer eye health. Serving more than 60 million patients a day across 103 countries, Johnson & Johnson Vision is committed to helping more people in more places improve or restore their sight. Dual headquartered in Jacksonville, Florida, and Santa Ana, California, Johnson & Johnson Vision has more than 10,000 employees worldwide.
1. Young G, Sulley A, Hunt C. Prevalence of astigmatism in relation to soft contact lens fitting. Eye Contact Lens. 2011; 37(1):20-25.
2. Nichols J, et al. A comparison of toric and spherical soft contact lenses on visual quality of life and ease of fitting in astigmatic patients. BCLA/NCC conference 2016.
3. JJV Data on file July 2017. Proportion astigmats accommodated with ACUVUE® Brand CLs for ASTIGMATISM
Important Information for Contact Lens Wearers: ACUVUE® Brand Contact Lenses are indicated for vision correction. As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Lenses should not be prescribed if patients have any eye infection, or experience eye discomfort, excessive tearing, vision changes, redness or other eye problems. Consult the package insert for complete information. Complete information is also available by visiting acuvueprofessional.com, or by calling Johnson & Johnson Vision Care, Inc. at 1-800-843-2020.
+ Helps protect against transmission of harmful UV radiation to the cornea and into the eye.
* WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. You should continue to use UV-absorbing eyewear as directed. NOTE: Long-term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities). UV-blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UV-blocking contact lenses reduces the risk of developing cataracts or other eye disorders. Consult your eye care practitioner for more information.
ACUVUE®, 1-DAY ACUVUE® MOIST, LACREON®, BLINK-STABILIZED® and EYE-INSPIRED™ are trademarks of Johnson & Johnson Vision Care, Inc.
© Johnson & Johnson Vision Care, Inc. 2018
Source: Johnson & Johnson
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsActelion Submits Supplemental New Drug Application to US FDA Seeking Approval of OPSUMIT(R) (macitentan) for the Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.
Johnson & Johnson Medical Devices Companies Acquire Orthotaxy to Develop Next-Generation Robotic-Assisted Surgery Platform in Orthopaedics